Get your hands on a copy of “The Great American Drug Deal” and listen to our expert talk about Generalized Cost-Effectiveness Analysis.
On Monday, May 6 11:30am to 12:30pm, ISPOR attendees will have the opportunity to meet Peter Kolchinsky, author of "The Great American Drug Deal”, founder of RA Capital and board member of No Patient Left Behind at the FIECON booth #913.
Peter is a staunch advocate for the Biotech Social Contract and Generalized Cost-Effectiveness Analysis (GCEA). Please visit to hear how the cost-effectiveness landscape is evolving in the US, through growing adoption of GCEA by investors and the industry.